Vogenx joins IPO queue to fund phase 2-stage metabolic drug
Vogenx joins IPO queue to fund phase 2-stage metabolic drug
Small Molecules for Metabolic Diseases
Company Info
Recent News
Vogenx joins IPO queue to fund phase 2-stage metabolic drug
Leadership Team
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer
Careers & Job Openings